96 related articles for article (PubMed ID: 30489433)
1. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
Jackson R; Wang L; Jembere N; Murphy J; Kupets R
J Low Genit Tract Dis; 2019 Jan; 23(1):1-6. PubMed ID: 30489433
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
3. Screening history in women with cervical cancer in a Danish population-based screening program.
Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
[TBL] [Abstract][Full Text] [Related]
4. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
Morgan EL; Sanday K; Budd A; Hammond IG; Nicklin J
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):469-472. PubMed ID: 28580578
[TBL] [Abstract][Full Text] [Related]
6. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
Vale DB; Braganca JF; Morais SS; Zeferino LC
Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
8. A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
Landy R; Mathews C; Robertson M; Wiggins CL; McDonald YJ; Goldberg DW; Scarinci IC; Cuzick J; Sasieni PD; Wheeler CM
Gynecol Oncol; 2020 Nov; 159(2):344-353. PubMed ID: 32977987
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
10. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
11. A population-based evaluation of cervical screening in the United States: 2008-2011.
Cuzick J; Myers O; Hunt WC; Robertson M; Joste NE; Castle PE; Benard VB; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):765-73. PubMed ID: 24302677
[TBL] [Abstract][Full Text] [Related]
12. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
13. Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.
Ibáñez R; Alejo M; Combalia N; Tarroch X; Autonell J; Codina L; Culubret M; Bosch FX; de Sanjosé S
Biomed Res Int; 2015; 2015():605375. PubMed ID: 26180804
[TBL] [Abstract][Full Text] [Related]
14. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological correlation of cervical carcinoma: a tertiary hospital based study.
Shruthi PS; Kalyani R; Kai LJ; Narayanaswamy M
Asian Pac J Cancer Prev; 2014; 15(4):1671-4. PubMed ID: 24641387
[TBL] [Abstract][Full Text] [Related]
16. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women.
Bulk S; Visser O; Rozendaal L; Verheijen RH; Meijer CJ
Int J Cancer; 2005 Mar; 113(6):1005-9. PubMed ID: 15515017
[TBL] [Abstract][Full Text] [Related]
18. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
Marquardt K; Stubbe M; Broschewitz U
Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
[TBL] [Abstract][Full Text] [Related]
19. Screening History in 313 Cases of Invasive Cancer: A Retrospective Review of Cervical Cancer Screening in Alberta, Canada.
Mema SC; Nation J; Yang H; Waghray R; Sun MC; Xu L; Kliewer G
J Low Genit Tract Dis; 2017 Jan; 21(1):17-20. PubMed ID: 27824788
[TBL] [Abstract][Full Text] [Related]
20. Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.
Castillo M; Astudillo A; Clavero O; Velasco J; Ibáñez R; de Sanjosé S
PLoS One; 2016; 11(8):e0161403. PubMed ID: 27547971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
